Envista Holdings Corporation
$27.85
▼
-0.35%
2026-04-21 08:32:00
envistaco.com
NYQ: NVST
Explore Envista Holdings Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.56 B
Current Price
$27.85
52W High / Low
$30.42 / $14.72
Stock P/E
97.1
Book Value
$18.96
Dividend Yield
—
ROCE
4.89%
ROE
1.56%
Face Value
—
EPS
$0.28
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
12,000
Beta
0.98
Debt / Equity
51.43
Current Ratio
2.38
Quick Ratio
2.04
Forward P/E
16.93
Price / Sales
1.59
Enterprise Value
$4.71 B
EV / EBITDA
13.03
EV / Revenue
1.73
Rating
Buy
Target Price
$28.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Anbio Biotechnology | $26.98 | 380.56 | $3.88 B | — | 11.61% | 27.05% | $55.65 / $6.05 | $0.63 |
| 2. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 3. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 4. | Bionano Genomics, Inc. | $1.31 | — | $14.53 M | — | -65.83% | -66.15% | $5.5 / $1.06 | $4.14 |
| 5. | Azenta, Inc. | $26.4 | — | $1.22 B | — | -1.19% | 1.53% | $41.73 / $19.87 | $37.26 |
| 6. | Baxter International Inc. | $18.8 | — | $9.79 B | 0.21% | 1.04% | -13.71% | $32.68 / $15.73 | $11.92 |
| 7. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 750.6 M | 669.9 M | 682.1 M | 616.9 M | 652.9 M | — |
| Operating Profit | 93 M | 57.5 M | 46.3 M | 47.4 M | 67.7 M | — |
| Net Profit | 32.9 M | -30.3 M | 26.4 M | 18 M | 1.2 M | — |
| EPS in Rs | 0.2 | -0.19 | 0.16 | 0.11 | 0.01 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.72 B | 2.51 B | 2.57 B | 2.57 B |
| Operating Profit | 235.8 M | 137.2 M | 314.9 M | 343.2 M |
| Net Profit | 47 M | -1.12 B | -100.2 M | 243.1 M |
| EPS in Rs | 0.29 | -6.86 | -0.61 | 1.49 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.68 B | 5.35 B | 6.61 B | 6.59 B |
| Total Liabilities | 2.57 B | 2.42 B | 2.43 B | 2.38 B |
| Equity | 3.11 B | 2.93 B | 4.17 B | 4.21 B |
| Current Assets | 2.03 B | 1.79 B | 1.74 B | 1.42 B |
| Current Liabilities | 852.6 M | 878.7 M | 780.8 M | 1.24 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 275.7 M | 336.5 M | 275.7 M | 182.7 M |
| Investing CF | -51.1 M | -54.6 M | -62.4 M | -657.3 M |
| Financing CF | -170.9 M | -103.7 M | 118.9 M | 12.5 M |
| Free CF | 230.4 M | 302.7 M | 217.5 M | 107 M |
| Capex | -45.3 M | -33.8 M | -58.2 M | -75.7 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -2.18% | -0.1% | — | — |
| Earnings Growth % | -1016.37% | -141.22% | — | — |
| Profit Margin % | -44.56% | -3.9% | 9.46% | — |
| Operating Margin % | 5.46% | 12.27% | 13.36% | — |
| Gross Margin % | 54.68% | 56.13% | 57.41% | — |
| EBITDA Margin % | -35.2% | 6.67% | 18.85% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.